Platelet‐rich plasma improves the therapeutic efficacy of mesenchymal stem cells by enhancing their secretion of angiogenic factors in a combined radiation and wound injury model

Delayed wound healing after radiation exposure can cause serious cutaneous damage, and its treatment is a major clinical challenge. Although mesenchymal stem cells (MSCs) have emerged as a promising therapeutic agent in regenerative medicine, they alone do not produce satisfactory effects in a combi...

Full description

Saved in:
Bibliographic Details
Published inExperimental dermatology Vol. 29; no. 2; pp. 158 - 167
Main Authors Myung, Hyunwook, Jang, Hyosun, Myung, Jae Kyung, Lee, Changsun, Lee, Janet, Kang, JiHoon, Jang, Won‐Suk, Lee, Sun‐Joo, Kim, Hyewon, Kim, Hwi‐Yool, Park, Sunhoo, Shim, Sehwan
Format Journal Article
LanguageEnglish
Published Denmark Wiley Subscription Services, Inc 01.02.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Delayed wound healing after radiation exposure can cause serious cutaneous damage, and its treatment is a major clinical challenge. Although mesenchymal stem cells (MSCs) have emerged as a promising therapeutic agent in regenerative medicine, they alone do not produce satisfactory effects in a combined radiation and wound injury (CRWI) model. Here, we investigated the therapeutic effect of combined umbilical cord blood‐derived (UCB)‐MSCs and platelet‐rich plasma (PRP) treatment on wound healing in a CRWI mouse model. First, we assessed the release of cytokines from UCB‐MSCs cultured with PRP and observed changes in the expression of angiogenic factors. The angiogenic paracrine factors from UCB‐MSCs cultured with PRP were assessed in human umbilical vein endothelial cells (HUVECs). To assess therapeutic efficacy, UCB‐MSCs and PRP were topically implanted into a CRWT mouse model. Vascular endothelial growth factor (VEGF), a pro‐angiogenic growth factor, urokinase‐type plasminogen activator and contributor to VEGF‐induced signalling were more highly expressed in conditioned media of UCB‐MSCs cultured with PRP than in that of UCB‐MSCs alone. Furthermore, conditioned media of UCB‐MSCs cultured with PRP increased the formation of tube‐like structures in HUVECs. Co‐treatment of UCB‐MSCs and PRP in a CRWI mouse model increased the wound closure rate and angiogenesis compared with an untreated irradiated group. Moreover, increased expression of VEGF and CD31 were observed in the wound tissue of co‐treated mice compared with untreated irradiated mice. PRP stimulates the release of angiogenic factors from UCB‐MSCs, and combined therapy of UCB‐MSCs and PRP improves regeneration efficacy by enhancing angiogenesis in a CRWI model.
Bibliography:Funding information
This study was supported by a grant from the Korea Institute of Radiological and Medical Sciences (KIRAMS), funded by Ministry of Science and ICT (MSIT), Republic of Korea, grant number 50535‐2019.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0906-6705
1600-0625
DOI:10.1111/exd.14042